http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103257229-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd4bdb71dd03dcdbec9fda2d3ae1dbb5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f61c31ab536c96b28aadaa75a6660082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b497c9e9616a7e43bbd0b777406f982c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8589bef0111818c3f88978e85ca73fa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d441e567489652b48a351becac9e5b5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9aad35fe8ba4ef13f5d67ddb1d0dc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b071925d90d82f6e73dd6efeb21771e8 |
| publicationDate | 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103257229-A |
| titleOfInvention | Method for evaluating prognosis of colorectal cancer patient through positive expression quantity of colorectal cancer immunological index CD3 |
| abstract | The invention discloses a method for evaluating prognosis of a colorectal cancer patient through positive expression quantity of colorectal cancer immunological index CD3. The method comprises the following steps of: firstly preparing a tissue wax block of the colorectal cancer patient into a tissue chip; then carrying out an immunohistochemical experiment and immune scoring; grouping according to immune score; drawing a graph by taking survival periods of patients, obtained by follow-up visit, with one group of low CD3 positive expression quantity and one group of high CD3 positive expression quantity as an x-coordinate, and taking the overall survival rate of the patients as a y-coordinate; and analyzing according to a relation between the survival period and the overall survival rate in the obtained graph to judge the CD3 positive expression quantity and a prognosis effect of the colorectal cancer patient. Under the condition of high CD3 positive expression quantity, the prognosis of the patient is relatively good; and under the condition of low CD3 positive expression quantity, the prognosis of the patient is relatively poor. The evaluation method is capable of predicting the prognosis of the colorectal cancer patient accurately and rapidly. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103487583-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115612742-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110646271-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109738640-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109738640-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107976442-A |
| priorityDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.